reviewNature Reviews Drug DiscoveryJul 7, 2017BRONZE OA

Opportunities and challenges in phenotypic drug discovery: an industry perspective

JGJohn G. MoffatFVFabien VincentJAJonathan A. LeeJEJörg EderMPMarco Prunotto

Pfizer (United States) · Eli Lilly (United States) · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

940
total citations
FWCI
32.07
Percentile
100%
References
125
Citations per year

Authors

5

Topics & keywords

Topics
Keywords
  • Drug discovery
  • Pharmaceutical industry
  • Identification (biology)
  • Data science
  • Phenotypic screening
  • Best practice
  • Computer science
  • Disease
No related works found for this paper.